Read + Share
Amedeo Smart
Independent Medical Education
Barrette AM, Ronk H, Joshi T, Mussa Z, et al. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor Verteporfin in preclinical glioblastoma models. Neuro Oncol 2021 Oct 17. pii: 6398692. doi: 10.1093.PMID: 34657158
Email
LinkedIn
Facebook
Twitter
Privacy Policy